Literature DB >> 26605695

Surrogates for Survival or Other End Points in Oncology.

Michael LeBlanc1, Catherine Tangen1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 26605695     DOI： 10.1001/jamaoncol.2015.4711

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  3 in total

1.  In search of effective therapies: the current landscape of phase II trials in patients with advanced soft tissue sarcoma.

Authors:  Paweł Sobczuk; Huber Bątruk; Paulina Wójcik; Krzysztof Iwaniak; Katarzyna Kozak; Piotr Rutkowski
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-01       Impact factor: 4.553

Review 2.  Two Decades of Cardiovascular Trials With Primary Surrogate Endpoints: 1990-2011.

Authors:  Behnood Bikdeli; Natdanai Punnanithinont; Yasir Akram; Ike Lee; Nihar R Desai; Joseph S Ross; Harlan M Krumholz
Journal:  J Am Heart Assoc       Date:  2017-03-21       Impact factor: 5.501

3.  Surrogate endpoints in advanced sarcoma trials: a meta-analysis.

Authors:  Marion Savina; Saskia Litière; Antoine Italiano; Tomasz Burzykowski; Franck Bonnetain; Sophie Gourgou; Virginie Rondeau; Jean-Yves Blay; Sophie Cousin; Florence Duffaud; Hans Gelderblom; Alessandro Gronchi; Ian Judson; Axel Le Cesne; Paul Lorigan; Joan Maurel; Winette van der Graaf; Jaap Verweij; Simone Mathoulin-Pélissier; Carine Bellera
Journal:  Oncotarget       Date:  2018-10-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.